文献速递中药与中成药合理使用中医内科

天然药物靶向程序性细胞死亡干预对乙酰氨基酚肝损伤研究进展

Advances on botanicals targeting programmed cell death in acetaminophen-induced liver injury.
PubMed 文献 · J Ethnopharmacol · 2026-03-02

综述近十年文献,聚焦对乙酰氨基酚诱导肝损伤(AILI)中程序性细胞死亡(PCD)机制,汇总9类结构天然产物及44种化合物的实验证据,发现汉防己碱、二氢杨梅素、鞣酸和紫檀芪等具潜力,可经Nrf2-HO1、NF-κB、RIPK/MLKL等通路减轻PCD。

要点

  • AILI中PCD是关键病理环节,天然产物可多通路调控。
  • 汉防己碱、二氢杨梅素、鞣酸、紫檀芪等显示较有前景。
  • NAC治疗窗窄且不良反应多,天然产物或为补充策略。

核心结论

  • 天然产物可经调控程序性细胞死亡通路减轻对乙酰氨基酚肝毒性,为肝保护药物开发提供思路。

研究设计与样本

  • 检索Web of Science、PubMed和CNKI近十年文献,关键词为APAP、AILI、天然产物和中药,排除未明确植物提取物成分的研究,最终纳入160余篇论文进行系统综述。

主要发现

  • 按生物活性结构将抗AILI植物提取物分为9类,比较44种天然化合物的实验证据。
  • 汉防己碱、二氢杨梅素、鞣酸和紫檀芪等为较有前景的化合物。
  • 多种天然产物衍生物可同时调节Nrf2-HO1、NF-κB和RIPK/MLKL等多条信号通路以缓解APAP所致PCD。

关键数值与推荐

  • 纳入160余篇论文,聚焦44种天然化合物的实验研究证据。
  • 植物提取物按化学结构分为9类。

临床怎么用

  • 关注天然产物对AILI相关PCD通路的调控,作为NAC治疗窗窄和不良反应多的潜在补充策略。

局限性

  • 综述基于临床前实验证据,未提供临床疗效与安全性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Acetaminophen (APAP), a widely used analgesic and antipyretic drug, poses a significant clinical challenge worldwide due to its potential to induce hepatotoxicity following overdose. At present, limited therapeutic options exist for APAP overdose. Moreover, N-acetylcysteine (NAC), the first-line clinical agent in routine use, suffers from a narrow therapeutic window and numerous adverse effects, which limits its clinical utility. Plants constitute a rich reservoir of phytochemicals that engage in multiple pharmacological processes, positioning them as a cornerstone in pharmaceutical innovation. The therapeutic use of herbs for liver conditions is historically recognized in classical works such as the "Treatise on Febrile Diseases," "Compendium of Materia Medica," and "Thousand Golden Prescriptions." AIM OF THE REVIEW: Chinese herbal medicines and their extracts have garnered significant attention for the prevention and treatment of acetaminophen (APAP)-induced liver injury (AILI), largely due to their therapeutic efficacy and favorable safety profile. The programmed cell death (PCD) induced by APAP, and the impact and potential mechanism on the pathogenesis of AILI are discussed in this review. Furthermore, various botanicals that can be used to prevent AILI, as well as the structure-activity relationships and potential mechanisms, are discussed. METHODS: Articles published over the past decade were retrieved from databases including Web of Science, PubMed, and CNKI, using the keywords APAP, AILI, natural products, and traditional Chinese medicine. Studies that failed to clearly characterize the components of plant extracts were excluded. Subsequently, a preliminary classification was performed based on the chemical structures of the included natural products, with priority given to relatively novel agents supported by robust research data or notable research advances. Following a systematic review and synthesis of key study details, including experimental design, phenotypic alterations, and mechanism elucidation, the decision was made to conduct further in-depth analysis focusing on the type of PCD. Ultimately, more than 160 papers were selected and discussed in this review. RESULTS: A systematic review of the literature identified plant extracts with anti-AILI properties, which can be categorized into nine distinct classes based on their bioactive structures. By comparing the experimental research evidence from 44 natural compounds, not only were several more promising compounds such as sinomenine, dihydromyricetin, tannic acid and pterostilbene obtained, but it also helped to clarify the protective mechanisms of these extracts. Studies have found that numerous derivatives of natural products are capable of concurrently modulating multiple signaling pathways, such as Nrf2-HO1, NF-κB, and RIPK/MLKL, to alleviate PCD caused by APAP, thereby offering potential strategies for the prevention or treatment of AILI. CONCLUSION: This review systematically elucidates the mechanisms by which structurally diverse phytochemicals alleviate APAP-induced hepatotoxicity, with a specific focus on their modulatory roles in programmed cell death pathways implicated in AILI. These findings provide valuable insights for the development of novel hepatoprotective therapeutics.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Ge Y, Luo N, Zhang M, et al. Advances on botanicals targeting programmed cell death in acetaminophen-induced liver injury. J Ethnopharmacol. 2026. PMID: 41780618. doi:10.1016/j.jep.2026.121466

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。